Alpha-synuclein repeat variants and survival in Parkinson's disease
View/ Open
File version
Accepted Manuscript (AM)
Author(s)
Chung, Sun Ju
Biernacka, Joanna M
Armasu, Sebastian M
Anderson, Kari
Frigerio, Roberta
Aasly, Jan O
Annesi, Grazia
Bentivoglio, Anna Rita
Brighina, Laura
Chartier-Harlin, Marie-Christine
Goldwurm, Stefano
Hadjigeorgiou, Georgios
Jasinska-Myga, Barbara
Jeon, Beom Seok
Kim, Yun Joong
Krueger, Rejko
Lesage, Suzanne
Markopoulou, Katerina
Mellick, George
Morrison, Karen E
Puschmann, Andreas
Tan, Eng-King
Crosiers, David
Theuns, Jessie
Van Broeckhoven, Christine
Wirdefeldt, Karin
Wszolek, Zbigniew K
Elbaz, Alexis
Maraganore, Demetrius M
Griffith University Author(s)
Year published
2014
Metadata
Show full item recordAbstract
Objectives To determine whether a-synuclein dinucleotide repeat (REP1) genotypes are associated with survival in Parkinson's disease (PD). Methods Investigators from the Genetic Epidemiology of Parkinson's Disease Consortium provided REP1 genotypes and baseline and follow-up clinical data for cases. The primary outcome was time to death. Cox proportional hazards regression models were used to assess the association of REP1 genotypes with survival. Results Twenty-one sites contributed data for 6,154 cases. There was no significant association between a-synuclein REP1 genotypes and survival in PD. However, there was a ...
View more >Objectives To determine whether a-synuclein dinucleotide repeat (REP1) genotypes are associated with survival in Parkinson's disease (PD). Methods Investigators from the Genetic Epidemiology of Parkinson's Disease Consortium provided REP1 genotypes and baseline and follow-up clinical data for cases. The primary outcome was time to death. Cox proportional hazards regression models were used to assess the association of REP1 genotypes with survival. Results Twenty-one sites contributed data for 6,154 cases. There was no significant association between a-synuclein REP1 genotypes and survival in PD. However, there was a significant association between REP1 genotypes and age at onset of PD (hazard ratio: 1.06; 95% confidence interval: 1.01-1.10; P value?=?0.01). Conclusions In our large consortium study, a-synuclein REP1 genotypes were not associated with survival in PD. Further studies of a-synuclein's role in disease progression and long-term outcomes are needed.
View less >
View more >Objectives To determine whether a-synuclein dinucleotide repeat (REP1) genotypes are associated with survival in Parkinson's disease (PD). Methods Investigators from the Genetic Epidemiology of Parkinson's Disease Consortium provided REP1 genotypes and baseline and follow-up clinical data for cases. The primary outcome was time to death. Cox proportional hazards regression models were used to assess the association of REP1 genotypes with survival. Results Twenty-one sites contributed data for 6,154 cases. There was no significant association between a-synuclein REP1 genotypes and survival in PD. However, there was a significant association between REP1 genotypes and age at onset of PD (hazard ratio: 1.06; 95% confidence interval: 1.01-1.10; P value?=?0.01). Conclusions In our large consortium study, a-synuclein REP1 genotypes were not associated with survival in PD. Further studies of a-synuclein's role in disease progression and long-term outcomes are needed.
View less >
Journal Title
Movement Disorders
Volume
29
Issue
8
Copyright Statement
© 2014 Movement Disorder Society. This is the pre-peer reviewed version of the following article: Alpha-synuclein repeat variants and survival in Parkinson's disease, Movement Disorders, Volume 29, Issue 8, July 2014, Pages 1053-1057, which has been published in final form at https://doi.org/10.1002/mds.25841. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving (http://olabout.wiley.com/WileyCDA/Section/id-828039.html)
Subject
Clinical sciences
Sports science and exercise
Neurosciences
Neurology and neuromuscular diseases